Qisda Corp
TWSE:2352

Watchlist Manager
Qisda Corp Logo
Qisda Corp
TWSE:2352
Watchlist
Price: 24.6 TWD 2.93% Market Closed
Market Cap: 38.9B TWD

Qisda Corp
Investor Relations

Qisda Corp., originally emerging from BenQ Corporation, has steadily charted its course within the competitive landscape of global technology solutions. Founded in Taiwan, Qisda began as a hardware manufacturer and burgeoned into a multifaceted company with interests spanning from IT products to healthcare solutions. The company’s DNA showcases its relentless pursuit of innovation alongside its commitment to delivering high-value products. By leveraging its extensive R&D capabilities, Qisda strives to integrate cutting-edge designs in its product offerings, ranging from monitors and projectors to sophisticated IoT solutions and medical devices. As the technology sphere evolves, Qisda has adeptly diversified its business portfolio, a strategy which secures its role as a key player in various technology-driven industries.

The crux of Qisda's business model revolves around manufacturing and design services, underpinning its prominence in the OEM and ODM sectors. The company generates revenue by offering its high-tech design and manufacturing expertise to numerous global brands, creating a foundation of trust and quality through its expansive production facilities and a diversified client base. Moreover, Qisda’s engagement in the medical sector, via its subsidiary BenQ Medical Technology, is not just a remarkable expansion but a strategic pivot towards a nascent and profitable frontier. By aligning its technological prowess with healthcare innovation, Qisda is not only fortifying its revenue streams but also enhancing its resilience against market fluctuations, ensuring long-term growth and sustainability.

Show more
Loading
2352
Taiwan Weighted Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Nov 6, 2024
AI Summary
Q3 2024

Quarterly Growth: Qisda posted third quarter revenue of NTD 50.8 billion, up 2% quarter-over-quarter, with profit and operating income also rising sequentially.

Margins: Gross margin hit 16.8%, the highest in 20 years, and has stayed above 16% for six consecutive quarters.

Segment Trends: IT Original business and Medical both showed revenue growth; NCG faced continued inventory digestion, but expects a rebound next year.

Fourth Quarter Outlook: Management expects the fourth quarter to outperform the third in both revenue and profit, with growth seen in most business groups.

Medical Expansion: The Norbel Baby (Ding Ding Drug Store) acquisition is progressing, with strategic integration planned for next year. Medical group revenue is not expected to hit NTD 30 billion in 2024 but should exceed that in 2025.

AI & Technology: The company is focusing on AIoT and smart solutions, with investments in edge computing, AI servers, and robotics driving future growth.

Geopolitical Preparedness: Management highlighted supply chain resilience and manufacturing readiness in Taiwan, China, and Vietnam to adapt to global uncertainty.

Sustainability Targets: Qisda reaffirmed its carbon reduction goals, aiming for 30% reduction by 2030 and net zero by 2050.

Key Financials
Revenue
NTD 50.8 billion
Gross Margin
16.8%
Operating Income
NTD 1.25 billion
EPS
NTD 0.54
Net Income Attributable to Qisda
NTD 1.05 billion
Year-to-date Revenue (First Three Quarters)
NTD 147.6 billion
Year-to-date Gross Margin (First Three Quarters)
16.5%
Year-to-date Operating Income (First Three Quarters)
NTD 3.5 billion
Year-to-date EPS (First Three Quarters)
NTD 1
Total Assets (End of September)
NTD 199.2 billion
Cash and Equivalents
NTD 27.4 billion
Inventory Turnover
88 days
Accounts Receivable Turnover
74 days
Other Earnings Calls

Management

Mr. Chi-Hong Chen
CEO & Chairman
No Bio Available
Mr. Han-Chou Huang
President & Director
No Bio Available
Ms. Chiu-Chin Hung
VP, CFO & Accounting Officer
No Bio Available
Ta-Wen Liou
Chief Accountant
No Bio Available
Mr. Danny Lin
VP and Chief HR, Sustainability & Risk Officer
No Bio Available
Ms. Wen-Fang Huang
President of the Network Communication Business Unit
No Bio Available
Mr. Harry Yang
VP & President of the Medical Devices Products Group
No Bio Available
Mr. Eric Lee
GM of Manufacturing Operations & MD of Qisda China
No Bio Available
Mr. L.. S. Wang
CIO
No Bio Available
Li-Wen Huang
Chief Information Security Officer
No Bio Available

Contacts

Address
TAOYUAN
TAOYUAN
No.157, Shan-Ying Road, Gueishan District
Contacts
+88633598800
www.qisda.com